Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (319)
ARTG (259)
Prescription medicine registration (23)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2025 (27)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (48)
2019 (26)
2018 (53)
2017 (35)
2016 (77)
2015 (2)
2014 (2)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

605 result(s) found, displaying 311 to 320

CIPROFLOXACIN-DRLA ciprofloxacin 500mg (as hydrochloride monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 July 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CIPROFLOXACIN-DRLA ciprofloxacin 250mg (as hydrochloride monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 July 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 5 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 40 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
REDDYMAX PLUS D-CAL alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tablet composite pack Cancelled under Section 30(1)(c) of the Act

26 May 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 and CALCIUM SANDOZ alendronic acid (as sodium) 70 mg and colecalciferol 140 ug tablet and calcium 500 mg tablet composite pack Cancelled under Section 30(1)(c) of the Act

13 May 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
REDDY'S-CARMUSTINE carmustine 100 mg powder for injection vial with diluent vial (319032)

12 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REDDY'S-CARMUSTINE carmustine 100 mg powder for injection vial with diluent vial.
CARMUSTINE DR REDDY'S carmustine 100 mg powder for injection vial with diluent vial (319027)

12 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CARMUSTINE DR REDDY'S carmustine 100 mg powder for injection vial with diluent vial.
CARMUSTINE-DRLA carmustine 100 mg powder for injection vial with diluent vial (319033)

12 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CARMUSTINE-DRLA carmustine 100 mg powder for injection vial with diluent vial.

Pages

First page
Previous page
…
Page 28
Page 29
Page 30
Page 31
Current page 32
Page 33
Page 34
Page 35
Page 36
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.